221 Publications (Page 1 of 9)
2021
Congenital Conditions of Hypophosphatemia in ChildrenImel, Erik ACalcified Tissue International, vol. 108, (no. 1), pp. 74-90, Jan 2021.
| Journal Article
Radiographic imaging, densitometry and disease severity in Autosomal dominant osteopetrosis type 2Ladd, Lauren M⋅Ladd, Lauren M⋅Ladd, Lauren M⋅Ladd, Lauren M⋅Ladd, Lauren M⋅Ladd, Lauren M⋅Imel, Erik A⋅Imel, Erik A⋅Imel, Erik A⋅Imel, Erik A⋅Imel, Erik A⋅Imel, Erik A⋅Niziolek, Paul J⋅Niziolek, Paul J⋅Niziolek, Paul J⋅Niziolek, Paul J⋅Niziolek, Paul J⋅Niziolek, Paul J⋅Warden, Stuart J⋅Warden, Stuart J⋅Warden, Stuart J⋅Warden, Stuart J⋅Warden, Stuart J⋅Warden, Stuart J⋅Liang, Yun⋅Liang, Yun⋅Liang, Yun⋅Liang, Yun⋅Liang, Yun⋅Liang, Yun⋅Econs, Michael J⋅Econs, Michael J⋅Econs, Michael J⋅Econs, Michael J⋅Econs, Michael J and Econs, Michael JSkeletal Radiology, vol. 50, (no. 5), pp. 903-913, May 2021.
| Journal Article
2020
Congenital Conditions of Hypophosphatemia in ChildrenImel, Erik AllenCalcified tissue international, 2020-Apr-23.
| Journal Article
Decades of research yields drug for bone diseaseEcons, Michael⋅Econs, Michael⋅Imel, Erik⋅Imel, Erik⋅White, Kenneth and White, KennethIndianapolis Business Journal, vol. 41, (no. 2), pp. 6C, 20200306.
| Journal Article
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical TrialsWolf, Myles⋅Wolf, Myles⋅Wolf, Myles⋅Rubin, Janet⋅Rubin, Janet⋅Rubin, Janet⋅Achebe, Maureen⋅Achebe, Maureen⋅Achebe, Maureen⋅Econs, Michael J⋅Econs, Michael J⋅Econs, Michael J⋅Peacock, Munro⋅Peacock, Munro⋅Peacock, Munro⋅Imel, Erik A⋅Imel, Erik A⋅Imel, Erik A⋅Thomsen, Lars L⋅Thomsen, Lars L⋅Thomsen, Lars L⋅Carpenter, Thomas O⋅Carpenter, Thomas O⋅Carpenter, Thomas O⋅Weber, Thomas⋅Weber, Thomas⋅Weber, Thomas⋅Brandenburg, Vincent⋅Brandenburg, Vincent⋅Brandenburg, Vincent⋅Zoller, Heinz⋅Zoller, Heinz and Zoller, HeinzJAMA, vol. 323, (no. 5), pp. 443, 2020-02-04.
| Journal Article
Enthesopathy, osteoarthritis and mobility in X-linked hypophosphatemiaImel, Erik AThe Journal of clinical endocrinology and metabolism, 2020-May-06.
| Journal Article
OR29-01 Long-Term Safety in Adults with X-Linked Hypophosphatemia (XLH) Treated with Burosumab, a Fully Human Monoclonal Antibody Against FGF23: Final Results of a Phase 3 TrialPerwad, Farzana⋅Portale, Anthony A⋅Carpenter, Thomas O⋅Briot, Karine⋅Imel, Erik Allen⋅Kamenicky, Peter⋅Weber, Thomas Joseph⋅Pitukcheewanont, Pisit⋅Cheong, Hae Il⋅De Beur, Suzanne Marie Jan⋅Imanishi, Yasuo⋅Ito, Nobuaki⋅Lachmann, Robin⋅Tanaka, Hiroyuki⋅Zhang, Lin⋅Skrinar, Alison⋅Rees, Linda and Insogna, Karl LeonardJournal of the Endocrine Society, vol. 4, (no. Supplement_1), 2020-05-08.
| Journal Article
Oral Iron Replacement Normalizes Fibroblast Growth Factor 23 in Iron‐Deficient Patients With Autosomal Dominant Hypophosphatemic RicketsImel, Erik A⋅Imel, Erik A⋅Imel, Erik A⋅Liu, Ziyue⋅Liu, Ziyue⋅Liu, Ziyue⋅Coffman, Melissa⋅Coffman, Melissa⋅Coffman, Melissa⋅Acton, Dena⋅Acton, Dena⋅Acton, Dena⋅Mehta, Rakesh⋅Mehta, Rakesh⋅Mehta, Rakesh⋅Econs, Michael J⋅Econs, Michael J and Econs, Michael JJournal of Bone and Mineral Research, vol. 35, (no. 2), pp. 238, February 2020.
| Journal Article
Sarcopenia, frailty and cachexia patients detected in a multisystem electronic health record databaseMoorthi, Ranjani N⋅Liu, Ziyue⋅El-Azab, Sarah A⋅Lembcke, Lauren R⋅Miller, Matthew R⋅Broyles, Andrea A and Imel, Erik ABMC Musculoskeletal Disorders, vol. 21, pp. 1-8, 2020.
| Journal Article
SUN-356 Burosumab Resulted in Greater Clinical Improvements Compared with Higher-dose Conventional Therapy in Children with X-linked Hypophosphatemia (XLH)Imel, Erik A⋅Chen, Angel⋅Chang, Ting⋅Roberts, Mary Scott and Ward, Leanne MarieJournal of the Endocrine Society, vol. 4, (no. Supplement_1), 2020-05-08.
| Journal Article
2019
011–X-Linked Hypophosphatemia (XLH): New Knowledge for Nurses Regarding Genetics, Pathophysiology and Clinical PresentationCouto, Isabel⋅Hart, Marian⋅Olear, Elizabeth⋅Imel, Erik A and Carpenter, Thomas OJournal of Pediatric Nursing, vol. 46, pp. 131, May-June 2019.
| Journal Article
Burosumab resulted in greater improvement in clinical outcomes than continuation with conventional therapy in younger (1-4 years-old) and older (5-12 years-old) children with X-linked hypophosphatemiaWard, Leanne⋅Imel, Erik⋅Whyte, Michael⋅Munns, Craig⋅Portale, Anthony⋅Hogler, Wolfgang⋅Simmons, Jill⋅Padidela, Raja⋅Namba, Noriyuki⋅Cheong, Hae⋅Nilsson, Ola⋅Mao, Meng⋅Skrinar, Alison⋅Chen, Chao-Yin⋅Martin, Javier San and Glorieux, FrancisBone Abstracts, 2019-07-31.
| Journal Article
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trialImel, Erik A⋅Imel, E.A.⋅Imel, Erik A⋅Imel, Erik A⋅Imel, Erik A⋅Glorieux, Francis H⋅Glorieux, F.H.⋅Glorieux, Francis H⋅Glorieux, Francis H⋅Glorieux, Francis H⋅Whyte, Michael P⋅Whyte, Michael P⋅Whyte, Michael P⋅Whyte, M.P.⋅Whyte, Michael P⋅Munns, Craig F⋅Munns, Craig F⋅Munns, C.F.⋅Munns, Craig F⋅Munns, Craig F⋅Ward, Leanne M⋅Ward, Leanne M⋅Ward, L.M.⋅Ward, Leanne M⋅Ward, Leanne M⋅Nilsson, Ola⋅Nilsson, Ola⋅Nilsson, Ola⋅Nilsson, Ola⋅Nilsson, O.⋅Simmons, Jill H⋅Simmons, J.H.⋅Simmons, Jill H⋅Simmons, Jill H⋅Simmons, Jill H⋅Padidela, R.⋅Padidela, Raja⋅Padidela, Raja⋅Padidela, Raja⋅Padidela, Raja⋅Namba, Noriyuki⋅Namba, Noriyuki⋅Namba, Noriyuki⋅Namba, N.⋅Namba, Noriyuki⋅Cheong, Hae Il⋅Cheong, H.I.⋅Pitukcheewanont, Pisit⋅Pitukcheewanont, Pisit⋅Pitukcheewanont, Pisit⋅Pitukcheewanont, Pisit⋅Pitukcheewanont, P.⋅Sochett, E.⋅Sochett, Etienne⋅Sochett, Etienne⋅Sochett, Etienne⋅Sochett, Etienne⋅Högler, W.⋅Högler, Wolfgang⋅Högler, Wolfgang⋅Högler, Wolfgang⋅Högler, Wolfgang⋅Muroya, Koji⋅Muroya, Koji⋅Muroya, K.⋅Muroya, Koji⋅Muroya, Koji⋅Tanaka, Hiroyuki⋅Tanaka, Hiroyuki⋅Tanaka, Hiroyuki⋅Tanaka, H.⋅Tanaka, Hiroyuki⋅Gottesman, Gary S⋅Gottesman, Gary S⋅Gottesman, Gary S⋅Gottesman, G.S.⋅Gottesman, Gary S⋅Biggin, Andrew⋅Biggin, Andrew⋅Biggin, Andrew⋅Biggin, A.⋅Biggin, Andrew⋅Perwad, Farzana⋅Perwad, Farzana⋅Perwad, Farzana⋅Perwad, Farzana⋅Perwad, F.⋅Mao, Meng⋅Mao, Meng⋅Mao, Meng⋅Mao, M.⋅Mao, Meng⋅Chao-Yin, Chen⋅Chao-Yin, Chen⋅Chen, C.-Y.⋅Chao-Yin, Chen⋅Chen, Chao-Yin⋅Skrinar, Alison⋅Skrinar, Alison⋅Skrinar, Alison⋅Skrinar, Alison⋅Skrinar, A.⋅San Martin, Javier⋅San Martin, J.⋅Portale, Anthony A⋅Portale, Anthony A⋅Portale, A.A.⋅Portale, Anthony A and Portale, Anthony AThe Lancet, vol. 393, (no. 10189), pp. 2427, 2019-06-15.
| Journal Article
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled PeriodPortale, Anthony A⋅Portale, Anthony⋅Carpenter, Thomas O⋅Carpenter, Thomas⋅Brandi, Maria⋅Brandi, Maria Luisa⋅Briot, Karine⋅Briot, Karine⋅Cheong, Hae⋅Cheong, Hae Ii⋅Cohen-Solal, Martine⋅Cohen-Solal, Martine⋅Crowley, Rachel⋅Crowley, Rachel⋅Jan De Beur, Suzanne⋅Jan De Beur, Suzanne⋅Eastell, Richard⋅Eastell, Richard⋅Imanishi, Yasuo⋅Imanishi, Yasuo⋅Imel, Erik A⋅Imel, Erik⋅Ing, Steven⋅Ing, Steven⋅Ito, Nobuaki⋅Ito, Nobuaki⋅Javaid, Muhammad⋅Javaid, Muhammad⋅Kamenicky, Peter⋅Kamenicky, Peter⋅Keen, Richard⋅Keen, Richard⋅Kubota, Takuo⋅Kubota, Takuo⋅Lachmann, Robin⋅Lachmann, Robin⋅Perwad, Farzana⋅Perwad, Farzana⋅Pitukcheewanont, Pisit⋅Pitukcheewanont, Pisit⋅Ralston, Stuart⋅Ralston, Stuart H⋅Takeuchi, Yasuhiro⋅Takeuchi, Yasuhiro⋅Tanaka, Hiroyuki⋅Tanaka, Hiroyuki⋅Weber, Thomas⋅Weber, Thomas J⋅Yoo, Han-Wook⋅Yoo, Han-Wook⋅Zhang, Lin⋅Zhang, Lin⋅Theodore-Oklota, Christina⋅Theodore-Oklota, Christina⋅Mealiffe, Matt⋅Mealiffe, Matt⋅San Martin, Javier⋅San Martin, Javier⋅Insogna, Karl and Insogna, KarlCalcified Tissue International, vol. 105, (no. 3), pp. 284, 20190915.
| Journal Article
Efficacy and safety of burosumab in children aged 1–4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trialWhyte, Michael P⋅Carpenter, Thomas O⋅Gottesman, Gary S⋅Mao, Meng⋅Skrinar, Alison⋅San Martin, Javier and Imel, Erik AThe Lancet Diabetes & Endocrinology, vol. 7, (no. 3), pp. 199, March 2019.
| Journal Article
FGF23 and Associated Disorders of Phosphate WastingGohil, Anisha and Imel, Erik APediatric endocrinology reviews : PER, vol. 17, (no. 1), pp. 34, 2019-Sep.
| Journal Article
FGF23, Hypophosphatemia, and Emerging TreatmentsImel, E.A.⋅Imel, Erik A⋅Imel, Erik A⋅Imel, Erik A⋅Biggin, Andrew⋅Biggin, Andrew⋅Biggin, A.⋅Biggin, Andrew⋅Schindeler, Aaron⋅Schindeler, Aaron⋅Schindeler, A.⋅Schindeler, Aaron⋅Munns, C.F.⋅Munns, Craig F⋅Munns, Craig F and Munns, Craig FJBMR Plus, vol. 3, (no. 8), pp. n/a, August 2019.
| Journal Article
Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patientsDeLacey, Sean⋅Liu, Ziyue⋅Broyles, Andrea⋅El-Azab, Sarah A⋅Guandique, Cristian F⋅James, Benjamin C and Imel, Erik ABone, vol. 127, pp. 392, October 2019.
| Journal Article
Interferon Gamma‐1b Does Not Increase Markers of Bone Resorption in Autosomal Dominant OsteopetrosisImel, Erik A⋅Imel, Erik A⋅Liu, Ziyue⋅Liu, Ziyue⋅Acton, Dena⋅Acton, Dena⋅Coffman, Melissa⋅Coffman, Melissa⋅Gebregziabher, Netsanet⋅Gebregziabher, Netsanet⋅Tong, Yan⋅Tong, Yan⋅Econs, Michael J and Econs, Michael JJournal of Bone and Mineral Research, vol. 34, (no. 8), pp. 1445, August 2019.
| Journal Article
Low Usage of Physical Activity Related Diagnostic Codes Among Indiana Medical Providers: 478 Board #316 May 29 11:00 AM - 12:30 PMKeith, Ni Cole⋅Keith, NiCole⋅Lembke, Lauren⋅Lembke, Lauren⋅Imel, Erik and Imel, ErikMedicine & Science in Sports & Exercise, vol. 51, (no. 6 Suppl), pp. 130, 2019-June.
| Journal Article
OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH)Imel, Erik⋅Whyte, Michael⋅Munns, Craig⋅Portale, Anthony⋅Ward, Leanne⋅Nilsson, Ola⋅Simmons, Jill⋅Padidela, Raja⋅Namba, Noriyuki⋅Cheong, Hae Il⋅Mao, Meng⋅Chen, Chao-Yin⋅Skrinar, Alison⋅San Martin, Javier and Glorieux, FrancisJournal of the Endocrine Society, vol. 3, (no. Supplement_1), 2019-04-15.
| Journal Article
OR13-3 Effects of Iron Isomaltoside versus Ferric Carboxymaltose on Hormonal Control of Phosphate Homeostasis: The PHOSPHARE-IDA04/05 Randomized Controlled TrialsWolf, Myles⋅Wolf, Myles⋅Rubin, Janet⋅Rubin, Janet⋅Achebe, Maureen⋅Achebe, Maureen⋅Econs, Michael⋅Econs, Michael⋅Peacock, Munro⋅Peacock, Munro⋅Imel, Erik⋅Imel, Erik⋅Thomsen, Lars⋅Thomsen, Lars⋅Carpenter, Thomas⋅Carpenter, Thomas⋅Weber, Thomas⋅Weber, Thomas⋅Zoller, Heinz and Zoller, HeinzJournal of the Endocrine Society, vol. 3, (no. Supplement_1), 2019-04-15.
| Journal Article
Pharmacological management of X‐linked hypophosphataemiaImel, Erik A⋅Imel, Erik A⋅White, Kenneth E and White, Kenneth EBritish Journal of Clinical Pharmacology, vol. 85, (no. 6), pp. 1198, June 2019.
| Journal Article
SUN-526 Prevalence of Hyperparathyroidism in X-Linked HypophosphatemiaDeLacey, Sean⋅Liu, Ziyue⋅Broyles, Andrea⋅El-Azab, Sarah⋅Guandique, Cristian⋅James, Benjamin and Imel, ErikJournal of the Endocrine Society, vol. 3, (no. Supplement_1), 2019-04-15.
| Journal Article
SUN-532 Interferon Gamma-1b Does Not Increase Markers of Bone Resorption in Autosomal Dominant OsteopetrosisImel, Erik⋅Imel, Erik⋅Liu, Ziyue⋅Liu, Ziyue⋅Acton, Dena⋅Acton, Dena⋅Coffman, Melissa⋅Coffman, Melissa⋅Gebregziabher, Netsanet⋅Gebregziabher, Netsanet⋅Tong, Yan⋅Tong, Yan⋅Econs, Michael and Econs, MichaelJournal of the Endocrine Society, vol. 3, (no. Supplement_1), 2019-04-15.
| Journal Article
